Search

Author/Creator Olshansky, B

3. Cardiovascular benefits outweigh risks in patients with atrial fibrillation in REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial). (14th October 2021)

Authors:
Olshansky, B; Bhatt, D; Miller, M; Steg, P G; Brinton, E A; Jacobson, T A; Ketchum, S B; Doyle Jr, R T; Juliano, R A; Jiao, L; Kowey, P; Reiffel, J A; Tardif, J.-C; Ballantyne, C M; Chung, M K
Journal:
European heart journal
Issue:
Volume 42(2021)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. REDUCE-IT: accumulation of data across prespecified interim analyses to final results. (25th November 2020)

Authors:
Olshansky, B; Bhatt, D; Miller, M; Steg, P.G; Brinton, E.A; Jacobson, T.A; Ketchum, S.B; Doyle, R.T; Juliano, R.A; Jiao, L; Granowitz, C; Tardif, J.-C; Mehta, C; Ballantyne, C.M; Chung, M.K
Journal:
European heart journal
Issue:
Volume 41:(2020)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗